Agile Therapeutics
AGRX
#10841
Rank
NZ$17.71 M
Marketcap
NZ$2.57
Share price
0.00%
Change (1 day)
324.09%
Change (1 year)

Earnings for Agile Therapeutics (AGRX)

Earnings in 2024 (TTM): -NZ$24.37 Million

According to Agile Therapeutics 's latest financial reports the company's current earnings are NZ$21.56 Million. In 2023 the company made an earning of -NZ$22.18 Million a decrease over its 2022 earnings that were of -NZ$8.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agile Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$24.37 Million9.86%
2023 -NZ$22.18 Million172.57%
2022 -NZ$8.14 Million-93.26%
2021 -NZ$0.13 Billion45.62%
2020 -NZ$82.85 Million161.98%
2019 -NZ$31.63 Million-2.78%
2018 -NZ$32.53 Million-27.47%
2017 -NZ$44.85 Million-10.16%
2016 -NZ$49.92 Million-14.2%
2015 -NZ$58.18 Million88.45%
2014 -NZ$30.88 Million41.72%
2013 -NZ$21.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.15 B-172,993.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.99 B-70,584.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.35 B-87,628.28%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
NZ$0.2 M-100.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.11 B-538.45%๐Ÿ‡บ๐Ÿ‡ธ USA